These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

284 related items for PubMed ID: 33241323

  • 1. Botulinum Toxin Type A for the Treatment of Post-traumatic Headache: A Randomized, Placebo-Controlled, Cross-over Study.
    Zirovich MD, Pangarkar SS, Manh C, Chen L, Vangala S, Elashoff DA, Izuchukwu IS.
    Mil Med; 2021 May 03; 186(5-6):493-499. PubMed ID: 33241323
    [Abstract] [Full Text] [Related]

  • 2. Botulinum toxin type A (BOTOX) for the prophylactic treatment of chronic daily headache: a randomized, double-blind, placebo-controlled trial.
    Mathew NT, Frishberg BM, Gawel M, Dimitrova R, Gibson J, Turkel C, BOTOX CDH Study Group.
    Headache; 2005 Apr 03; 45(4):293-307. PubMed ID: 15836565
    [Abstract] [Full Text] [Related]

  • 3. Botulinum toxin type a for the prophylaxis of chronic daily headache: subgroup analysis of patients not receiving other prophylactic medications: a randomized double-blind, placebo-controlled study.
    Dodick DW, Mauskop A, Elkind AH, DeGryse R, Brin MF, Silberstein SD, BOTOX CDH Study Group.
    Headache; 2005 Apr 03; 45(4):315-24. PubMed ID: 15836567
    [Abstract] [Full Text] [Related]

  • 4. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
    Cady R, Schreiber C.
    Headache; 2008 Jun 03; 48(6):900-13. PubMed ID: 18047501
    [Abstract] [Full Text] [Related]

  • 5. Regional Targeted Subcutaneous Injection of Botulinum Neurotoxin Type A in Refractory Chronic Migraine: A Randomized, Double-Blind, Placebo-Controlled Study.
    Bono F, Mazza MR, Magro G, Spano G, Idone G, Laterza V, Tedeschi D, Pucci F, Gambardella A, Sarica A.
    Toxins (Basel); 2023 May 09; 15(5):. PubMed ID: 37235358
    [Abstract] [Full Text] [Related]

  • 6. Clinical efficacy of escitalopram combined with botulinum toxin A in patients with generalized anxiety disorder and comorbid headache.
    Wang Y, Yang X, Ji X, Liu M, Zhou C.
    Psychopharmacology (Berl); 2023 Oct 09; 240(10):2061-2070. PubMed ID: 37481677
    [Abstract] [Full Text] [Related]

  • 7. Botulinum toxin type a prophylactic treatment of episodic migraine: a randomized, double-blind, placebo-controlled exploratory study.
    Aurora SK, Gawel M, Brandes JL, Pokta S, Vandenburgh AM, BOTOX North American Episodic Migraine Study Group.
    Headache; 2007 Apr 09; 47(4):486-99. PubMed ID: 17445098
    [Abstract] [Full Text] [Related]

  • 8. Botulinum toxin type B vs. type A in toxin-naïve patients with cervical dystonia: Randomized, double-blind, noninferiority trial.
    Pappert EJ, Germanson T, Myobloc/Neurobloc European Cervical Dystonia Study Group.
    Mov Disord; 2008 Mar 15; 23(4):510-7. PubMed ID: 18098274
    [Abstract] [Full Text] [Related]

  • 9. Randomized controlled pilot trial of prazosin for prophylaxis of posttraumatic headaches in active-duty service members and veterans.
    Mayer CL, Savage PJ, Engle CK, Groh SS, Shofer JB, Hargrove AM, Williams TJ, Poupore EL, Hart KL, Riechers RG, Ruff RL, Peskind ER, Raskind MA.
    Headache; 2023 Jun 15; 63(6):751-762. PubMed ID: 37313689
    [Abstract] [Full Text] [Related]

  • 10. Botulinum toxin type-A in the prophylactic treatment of medication-overuse headache: a multicenter, double-blind, randomized, placebo-controlled, parallel group study.
    Sandrini G, Perrotta A, Tassorelli C, Torelli P, Brighina F, Sances G, Nappi G.
    J Headache Pain; 2011 Aug 15; 12(4):427-33. PubMed ID: 21499747
    [Abstract] [Full Text] [Related]

  • 11. Botulinum type A toxin complex for the relief of upper back myofascial pain syndrome: how do fixed-location injections compare with trigger point-focused injections?
    Benecke R, Heinze A, Reichel G, Hefter H, Göbel H, Dysport myofascial pain study group.
    Pain Med; 2011 Nov 15; 12(11):1607-14. PubMed ID: 21692970
    [Abstract] [Full Text] [Related]

  • 12. Botulinum toxin type a injections for cervical and shoulder girdle myofascial pain using an enriched protocol design.
    Nicol AL, Wu II, Ferrante FM.
    Anesth Analg; 2014 Jun 15; 118(6):1326-35. PubMed ID: 24842179
    [Abstract] [Full Text] [Related]

  • 13. Botulinum toxin A for prophylactic treatment of migraine and tension headaches in adults: a meta-analysis.
    Jackson JL, Kuriyama A, Hayashino Y.
    JAMA; 2012 Apr 25; 307(16):1736-45. PubMed ID: 22535858
    [Abstract] [Full Text] [Related]

  • 14. Botulinum Toxin versus Placebo: A Meta-Analysis of Prophylactic Treatment for Migraine.
    Bruloy E, Sinna R, Grolleau JL, Bout-Roumazeilles A, Berard E, Chaput B.
    Plast Reconstr Surg; 2019 Jan 25; 143(1):239-250. PubMed ID: 30589800
    [Abstract] [Full Text] [Related]

  • 15. Efficacy of botulinum toxin type A for the prophylaxis of episodic migraine headaches: a meta-analysis of randomized, double-blind, placebo-controlled trials.
    Shuhendler AJ, Lee S, Siu M, Ondovcik S, Lam K, Alabdullatif A, Zhang X, Machado M, Einarson TR.
    Pharmacotherapy; 2009 Jul 25; 29(7):784-91. PubMed ID: 19558252
    [Abstract] [Full Text] [Related]

  • 16. Is botulinum toxin A effective for the treatment of plantar fasciitis?
    Peterlein CD, Funk JF, Hölscher A, Schuh A, Placzek R.
    Clin J Pain; 2012 Jul 25; 28(6):527-33. PubMed ID: 22673486
    [Abstract] [Full Text] [Related]

  • 17. Duration of migraine is a predictor for response to botulinum toxin type A.
    Eross EJ, Gladstone JP, Lewis S, Rogers R, Dodick DW.
    Headache; 2005 Apr 25; 45(4):308-14. PubMed ID: 15836566
    [Abstract] [Full Text] [Related]

  • 18. OnabotulinumtoxinA for treatment of chronic migraine: pooled results from the double-blind, randomized, placebo-controlled phases of the PREEMPT clinical program.
    Dodick DW, Turkel CC, DeGryse RE, Aurora SK, Silberstein SD, Lipton RB, Diener HC, Brin MF, PREEMPT Chronic Migraine Study Group.
    Headache; 2010 Jun 25; 50(6):921-36. PubMed ID: 20487038
    [Abstract] [Full Text] [Related]

  • 19. Onabotulinum toxin-A injections for sleep bruxism: A double-blind, placebo-controlled study.
    Ondo WG, Simmons JH, Shahid MH, Hashem V, Hunter C, Jankovic J.
    Neurology; 2018 Feb 13; 90(7):e559-e564. PubMed ID: 29343468
    [Abstract] [Full Text] [Related]

  • 20. Clinical profile of botulinum toxin A in patients with chronic headaches and cervical dystonia: a prospective, open-label, longitudinal study conducted in a naturalistic clinical practice setting.
    Dowson AJ, Kilminster SG, Salt R.
    Drugs R D; 2008 Feb 13; 9(3):147-58. PubMed ID: 18457467
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.